Pre-made Omalizumab benchmark antibody ( Whole mAb, anti-IGHE therapeutic antibody) for drug discovery and mechanism of action (MOA) research
Cat No.: GMP-Bios-ab-398
Anti-IGHE therapeutic antibody (Pre-made Omalizumab biosimilar,Whole mAb) is a biosimilar expressed by mammalian cell line as a benchmark reference therapeutic antibody for biological drug disovery items including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Omalizumab, sold under the brand name Xolair, is a medication used to treat asthma, nasal polyps, and urticaria.
Delivery impact due to the Coronavirus Outbreak
With the COVID-19 outbreak in the world, many flights have been cancelled. In order for the customer to receive the goods properly, we use the FedEx Customized Freight (FCF) of Fedex which demands a higher fee. If the delivery fee is more expensive in your area, we will contact you by mail.
|Catalog No.||Package||Price(In USD)||Qty (Quantity)||Sum(In USD)|
|Products Name (INN Index)||Anti-IGHE therapeutic antibody (Pre-made Omalizumab biosimilar,Whole mAb)|
|Highest_Clin_Trial (Jan '20)||Approved|
|100% SI Structure||4x7s:HL/2xa8:HL/4x7t:HL:AB/5hys:HL:AB:EF:CD/6tcm:HL/6tcn:HL/6tco:BA/6tcp:HL|
|99% SI Structure||5g64:IM:HL|
|95-98% SI Structure||None|
|Companies||Dana-Farber Cancer Institute;Genentech;John Hopkins University;Novartis|
|Conditions Approved||Allergic asthma;Urticaria|
|Conditions Active||Seasonal allergic rhinitis;Nasal polyps;Mastocytosis;Asthma;Nephritis|
|Conditions Discontinued||Hypersensitivity;Peanut hypersensitivity|